Eliminate Allergy and Asthma Triggers From Schools to Support National Healthy Schools Day

Asthma is the main reason why children miss school. In fact, children in the U.S. miss about 13.8 million school days each year due to asthma. Missing school can affect many children's grades and well-being. Controlling asthma triggers at home can help reduce asthma symptoms. But what about at school? If kids are exposed to triggers at school, managing asthma at home will be a losing battle. Children are the most affected by air pollution and poor indoor air quality. The Asthma and Allergy...

FDA Approves Dupixent® for Moderate-to-Severe Atopic Dermatitis in Adolescents

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent® (dupilumab) for adolescent patients 12 to 17 years of age with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Dupixent can be used with or without topical corticosteroids.

Post
×
×
×
×